目的探讨运用纤维支气管镜灌洗联合穿心莲内酯口服治疗支气管扩张急性加重期患者的临床效果。方法选取支气管扩张急性加重期患者142例为研究对象,随机分为观察组和对照组,每组71例,对照组患者运用纤维支气管镜灌洗治疗,观察组患者在行支气管镜灌洗治疗的基础上加服穿心莲内酯胶囊治疗,比较两组患者的临床治疗效果。结果治疗前,两组患者的IL-6、Hs-CRP水平比较,差异无有统计学意义(P>0.05);治疗后,两组患者的IL-6、Hs-CRP水平均显著降低(P<0.01),观察组患者的IL-6、Hs-CRP水平显著低于对照组(P<0.01)。观察组患者喘息、咳嗽、肺部湿啰音、咳痰等症状体征消失时间均显著短于对照组(P<0.05)。结论穿心莲内酯联合纤维支气管镜灌洗治疗支气管扩张急性加重期患者,可显著降低炎症因子水平,提高临床治疗效果。
Objective To investigate the clinical efficacy of andrographolide combined with fiberoptic bronchoscopy in the treatment of acute exacerbation of bronchiectasis. Methods142 cases of acute exacerbation of bronchiectasis were selected and were randomly divided into observation group and control group, with 71 cases in each group. The control group were treated with fiberoptic bronchoscopy, and the observation group were treated with andrographolide Capsule on the basis of bronchoscopy irrigation. The clinical effects of the two groups were compared. ResultThere was no significant difference in the level of IL-6 and Hs-CRP between the two groups before treatment(P>0.05). After treatment, the levels of IL-6 and Hs-CRP in the two groups were significantly decreased (P<0.01). The level of IL-6 and Hs-CRP in the observation group was significantly lower than that of the control group (P<0.01). The disappearance time of the symptoms in the observation group was significantly shorter than that of the control group (P<0.05), such as wheezing, cough, lung rale and expectoration. ConclusionAndrographolide combined with bronchoscopy lavage in the treatment of acute exacerbation of bronchiectasis can significantly reduce the level of inflammatory factors and improve the clinical effect.